Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Receptors, Androgen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01790126
What this trial is testing

The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Aragon Pharmaceuticals, Inc. 90
Not applicableLooking for participantsNCT06141993
What this trial is testing

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Cancer Metastatic+1 more
Duke University 120
Testing effectiveness (Phase 2)Ended earlyNCT00918385
What this trial is testing

Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 57
Large-scale testing (Phase 3)Looking for participantsNCT07751133
What this trial is testing

Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer

Who this might be right for
Prostate CancermHSPCmCRPC
University College, London 1,500
Testing effectiveness (Phase 2)Study completedNCT00755885
What this trial is testing

Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Cancer Research UK 77
Early research (Phase 1)Looking for participantsNCT05413421
What this trial is testing

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
ORIC Pharmaceuticals 275
Early research (Phase 1)Ended earlyNCT03478904
What this trial is testing

Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Study completedNCT00468715
What this trial is testing

Bicalutamide in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05658003
What this trial is testing

A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 63
Testing effectiveness (Phase 2)UnknownNCT04033432
What this trial is testing

SEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaCastration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents+7 more
Northwestern University 14
Large-scale testing (Phase 3)Looking for participantsNCT04916613
What this trial is testing

ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

Who this might be right for
Prostate Cancer Metastatic
UNICANCER 300
Early research (Phase 1)Study completedNCT01052870
What this trial is testing

Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia
HairDx, LLC 12
Early research (Phase 1)Study completedNCT02411786
What this trial is testing

A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 40
Testing effectiveness (Phase 2)Study completedNCT05674045
What this trial is testing

A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary Incontinence

Who this might be right for
Stress Urinary Incontinence
Changchun GeneScience Pharmaceutical Co., Ltd. 51
Not applicableLooking for participantsNCT07223372
What this trial is testing

An Observational Study to Learn More About How Medicines That Block Male Hormones Are Used in People With Prostate Cancer in Australia

Who this might be right for
Metastatic Hormonesensitive Prostate Cancer (mHSPC)
Bayer 1,000
Testing effectiveness (Phase 2)Study completedNCT00769795
What this trial is testing

Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 29